These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14145972)

  • 21. [Importance of repeated immunological stimulation using BCG in the treatment of lepromatous leprosy. New evaluation of 13 patients].
    Ruscher H; Faye I; Languillon J; Sarrat H; Oudart JL; Carnus H
    Bull Soc Med Afr Noire Lang Fr; 1973; 18(4):470-6. PubMed ID: 4599200
    [No Abstract]   [Full Text] [Related]  

  • 22. Skin testing with mycobacterial reagents in leprosy.
    Stanford JL
    Tubercle; 1984 Mar; 65(1):63-74. PubMed ID: 6203199
    [No Abstract]   [Full Text] [Related]  

  • 23. EXPERIMENTAL INOCULATION OF HUMAN LEPROSY IN LABORATORY ANIMALS. 3.
    CONVIT J; LAPENTA P; ILUKEVICH A; IMAEDA T
    Int J Lepr; 1964; 32():136-49. PubMed ID: 14205618
    [No Abstract]   [Full Text] [Related]  

  • 24. LEPROSY TODAY.
    EDWARDS RH
    Lepr Rev; 1964 Jan; 35():3-13. PubMed ID: 14114050
    [No Abstract]   [Full Text] [Related]  

  • 25. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients.
    Cree IA; Smith WC; Beck JS
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.
    Weir RE; Brennan PJ; Butlin CR; Dockrell HM
    Clin Exp Immunol; 1999 May; 116(2):263-9. PubMed ID: 10337017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience and lessons from the use of lepromin and Mycobacterium leprae-specific serology.
    Sengupta U
    Lepr Rev; 2000 Dec; 71 Suppl():S63-6. PubMed ID: 11201890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FIELD METHOD FOR CONCENTRATING MYCOBACTERIUM LEPRAE IN SKIN BIOPSY SPECIMENS.
    KAR S; ELLISTON EP; TAYLOR CE
    Int J Lepr; 1964; 32():18-23. PubMed ID: 14192035
    [No Abstract]   [Full Text] [Related]  

  • 29. THE CONCENTRATION OF M. LEPRAE IN CURRENTLY AVAILABLE LEPROMINS.
    LECHAT MF; HANKS JH
    Int J Lepr; 1963; 31():348-52. PubMed ID: 14132394
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CORRELATION BETWEEN THE REACTIONS TO LEPROLIN AND LEPROMIN IN PERSONS HYPERSENSITIVE TO M. LEPRAE.
    OLMOSCASTRO N; ARCURI PB
    Int J Lepr; 1963; 31():211-7. PubMed ID: 14086705
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy.
    Martinez AN; Britto CF; Nery JA; Sampaio EP; Jardim MR; Sarno EN; Moraes MO
    J Clin Microbiol; 2006 Sep; 44(9):3154-9. PubMed ID: 16954241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ELECTRON MICROSCOPIC STUDY OF BORDERLINE LEPROSY.
    IMAEDA T; CONVIT J; LAPENTA P
    Int J Lepr; 1963; 31():389-417. PubMed ID: 14166266
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrapatient comparison of Mycobacterium leprae by VNTR analysis in nasal secretions and skin biopsy in a Brazilian leprosy endemic region.
    Lima LNGC; Fontes ANB; Li W; Suffys PN; Vissa VD; Mota RMS; Almeida RLF; Pontes MA; Gonçales HS; Frota CC; Rodrigues LC; Kendall C; Kerr LRFS
    Lepr Rev; 2016 Dec; 87(4):486-500. PubMed ID: 30226353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE ISOPATHIC PHENOMENON OF SAGHER. PRELIMINARY REPORT ON LEPROSY PATIENTS IN THE PHILIPPINES.
    REYES-JAVIER PD
    Lepr Rev; 1964 Apr; 35():97-102. PubMed ID: 14143118
    [No Abstract]   [Full Text] [Related]  

  • 37. [SOME OBSERVATIONS CONCERNING THE THEORY OF ANTAGONISM BETWEEN TUBERCULOSIS AND LEPROSY].
    CHAUSSINAND R
    Acta Trop; 1964; 21():82-7. PubMed ID: 14141442
    [No Abstract]   [Full Text] [Related]  

  • 38. IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS.
    SHEPARD CC; GUINTO RS
    J Exp Med; 1963 Aug; 118(2):195-204. PubMed ID: 14074384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A TRIAL OF BCG VACCINATION IN THE PROPHYLAXIS OF LEPROSY.
    BROWN JA; STONE MM
    Lepr Rev; 1963 Jul; 34():118-22. PubMed ID: 14046697
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients.
    van der Vliet GM; Cho SN; Kampirapap K; van Leeuwen J; Schukkink RA; van Gemen B; Das PK; Faber WR; Walsh GP; Klatser PR
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):396-403. PubMed ID: 9030105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.